CalciMedica, Inc. Share Price
NASDAQ: CALC | Micro CapCalciMedica, Inc. Stock Performance
CalciMedica, Inc. Share Price Chart
CalciMedica, Inc. Quarterly Profit & Loss
All figures in USD
CalciMedica, Inc. Annual Profit & Loss
All figures in USD
About CalciMedica, Inc.
CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. The company's lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. It also develops Auxora for the treatment of acute ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory indications. The company is based in La Jolla, California.
CalciMedica, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Sep 2026 | $2.13 | $1.93 | +312.39% |
Aug 2026 | $0.96 | $0.47 | -52.24% |
Jul 2026 | $0.98 | $0.98 | +0.20% |
Jun 2026 | $0.85 | $0.98 | +25.38% |
May 2026 | $0.61 | $0.78 | +36.84% |
Apr 2026 | $0.59 | $0.57 | +5.56% |
Mar 2026 | $0.49 | $0.54 | +4.25% |
Feb 2026 | $0.78 | $0.52 | -42.12% |
Jan 2026 | $6.63 | $0.90 | -86.56% |
Dec 2025 | $4.34 | $6.66 | +57.82% |
Nov 2025 | $3.00 | $4.22 | +42.57% |
Oct 2025 | $3.15 | $2.96 | -5.73% |
CALC Share Price FAQs
What is CalciMedica, Inc. share price today?
What is the 52 week high and 52 week low of CalciMedica, Inc. stock?
What is CALC's market capitalisation today?
What is CALC's net income for the last quarter?
What is the 5 year returns of CALC?
What is the high & low stock price of CALC today?
Can I buy CALC shares in India?